FurchgottR.F., and ZawadzkiJ.V.. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.Nature1980; 288; 373–6.
2.
IgnarroL.J., BugaG.M., WoodK.S., ByrnsR.E., and ChaudhuriG.. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide.Proc Natl Acad Sci U S A1987; 84; 9265–9.
3.
PalmerR.M., FerrigeA.G., and MoncadaS.. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor.Nature1987; 327; 524–6.
4.
PalmerR.M., ReesD.D., AshtonD.S., and MoncadaS.. L arginine is the physiologi cal precursor for the formation of nitric oxide in endothelium dependent relaxation.Biochem Biophys Res Commun1988; 153; 1251–6.
5.
ReesD.D., PalmerR.M.J., and MoncadaS.. Role of endothelium derived nitric oxide in the regulation of blood pressure.Proc Natl Acad Sci USA1989; 86; 3375–8.
6.
VallanceP., CollierJ., and MoncadaS.. Effects of endothelium derived nitric oxide on peripheral arteriolar tone in man.Lancet1989; 2; 997–1000.
7.
KilbournR.G., and GriffithO.W.. Overproduction of nitric oxide in cytokine mediated and septic shock.J Natl Cancer Inst1992; 84; 827–31.
8.
OchoaJ.B., CurtiB., PeitzmanAB. Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes.J Natl Cancer Inst1992; 84; 864–7.
9.
HibbsJ.B.J., WestenfelderC., TaintorR. Evidence for cytokineinducible nitric oxide synthesis from Largi-nine in patients receiving interleukin2 therapy.J Clin Invest1992; 89; 867–77.
10.
MoncadaS., PalmerR.M., and HiggsE.A.. Nitric oxide: physiology, pathophysiology, and pharmacology.Pharmacol Rev1991; 43; 109–42.
11.
HibbsJ.B.J., TaintorR.R., VavrinZ., and RachlinE.M.. Nitric oxide: a cytotoxic activated macrophage effector molecule.Biochem Biophys Res Commun1988; 157; 87–94.
12.
GerlachH., RossaintR., PappertD., KnorrM., and FalkeK.J.. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx.Lancet1994; 343; 518–9.
13.
RimarS., and GillisC.N.. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation.Circulation1993; 88; 2884–7.
FrostellC., FratacciM.D., WainJ.C., JonesR., and ZapolW.M.. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.Circulation1991; 83; 2038–47.
16.
PisonU., LopezF.A., HeidelmeyerC.F., RossaintR., and FalkeK.. Inhaled nitric oxide selectively reverses hypoxic pulmonary vasoconstriction without impairing pulmonary gas exchange.J Appl Physiol1993; 74; 1287–92.
17.
RossaintR., FalkeK.J., LopezF., SlamaK., PisonU., and ZapolW.M.. Inhaled nitric oxide in adult respiratory distress syndrome.N Engl J Med1993; 328; 399–405.
18.
BigatelloL.M., HurfordW.E., KacmarekR.M., RobertsJ.D.Jr., and ZapolW.M.. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation.Anesthesiology1994; 80; 761–70.
19.
PuybassetL., StewartT., RoubyJJ. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome.Anesthesiology1994; 80; 1254–67.
20.
RossaintR., SlamaK., SteudelW. Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome.Intensive Care Med1995; 21; 197–203.
21.
RossaintR., GerlachH., SchmidtRunke H. Efficacy of nitric oxide inhalation in severe ARDS.Chest1995; 107; 1107–15.
22.
BenzingA., and GeigerK.. Inhaled nitric oxide lowers pulmonary capillary pressure and changes longitudinal distribution of pulmonary vascular resistance in patients with acute lung injury.Acta Anaesthesiol Scand1994; 38; 640–5.
23.
WysockiM., VignonP., RoupieE. Improvement in right ventricular function with inhaled nitric oxide in patients with the adult respiratory distress syndrome (ARDS) and permissive hypercapnia.Am Rev Respir Dis1993; 147; A350
24.
BarberR.E., LeeJ., and HamiltonW.K.. Oxygen toxicity in man. A prospective study in patients with irreversible brain damage.N Engl J Med1970; 283; 1478–84.
25.
HaschekW.M., ReiserK.M., KleinSzanto AJ. Potentiation of butylated hydroxytolueneinduced acute lung damage by oxygen. Cell kinetics and collagen metabolism.Am Rev Respir Dis1983; 127; 28–34.
26.
KolobowT., MorettiM.P., FumagalliR. Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study.Am Rev Respir Dis1987; 135; 312–5.
27.
HicklingK.G., WalshJ., HendersonS., and JacksonR.. Low mortality rate in adult respiratory distress syndrome using low volume, pressure limited ventilation with permissive hypercapnia: A prospective study.Crit Care Med1994; 22; 1568–78.
28.
SchererR.. Independent lung ventilation.Int Care World1989; 6; 27–31.
29.
PappertD., RossaintR., SlamaK., GrüningT., and FalkeK.. Positioning in severe ARDS influences ventilation/perfusion relationships of the lung.Chest1994; 106; 1511–6.
30.
FishmanA.P.. Down with the good lung (editorial).N Engl J Med1981; 304; 537–8.
GattinoniL., PesentiA., MascheroniD. Low frequency positive pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure.JAMA1986; 256; 881–6.
33.
HillJ.D., O'BrienT.G., MurrayJJ. Prolonged extracorporeal oxygenation for acute posttraumatic respiratory failure (shock lung syndrome). Use of the Bramson membrane lung.N Engl J Med1972; 286; 629–34.
34.
ZapolW.M., SniderM.T., HillJD. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study.JAMA1979; 242; 2193–6.
35.
PesentiA., GattinoniL., and BombinoM.. Long term extracorporeal respiratory support: 20 years of progress.Intensive Care & Critical Care Digest1993; 12(2); 15–7.
36.
DreyfussD., and SaumonG.. Barotrauma is volutrauma, but which volume is the responsible?Intensive Care Med1992; 18; 139–41.
37.
AshbaughD.G., BigelowD.B., PettyT.L., and LevineB.E.. Acute respiratory distress in adults.Lancet1967; 2; 319–23.
SuchytaM.R., ClemmerT.P., OrmeJ.F.J., MorrisA.H., and ElliottC.G.. Increased survival of ARDS patients with severe hypoxemia (ECMO criteria).Chest1991; 99; 951–5.
40.
MorrisA.H., WallaceC.J., MenloveRL. Randomized clinical trial of pressurecontrolled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.Am J Respir Crit Care Med1994; 149; 295–305.
